HSCS Stock: HeartSciences Inc. Stock Price, Analysis & Insights
Get live hscs stock price $2.36, comprehensive HeartSciences Inc. stock analysis, charts, news, and expert forecast. Real-time hscs stock data and investment insights.
Loading chart...
Company Overview
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
Company Information
- CEO
- Andrew Simpson
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 15
Contact Information
- Website
- https://heartsciences.com
- Address
- 550 Reserve Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.58)
Business Model & Strategy
HeartSciences Inc. operates in the Medical - Devices industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Andrew Simpson, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Devices model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
HeartSciences Inc. competes in the Medical - Devices within the broader Healthcare. With 5.3 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, HeartSciences Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating HeartSciences Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for HeartSciences Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for HeartSciences Inc.
- ⚠Investors should consider how HeartSciences Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
5.30M
P/E Ratio
-0.29
Beta
2.58
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 5.30M market capitalization
- Trading Volume: 192.55K shares traded today
- Price Range: 52-week range of $2.01 - $6.47
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for HeartSciences Inc.
HeartSciences Inc. (HSCS) operates in the Medical - Devices industry within the Healthcare sector. With a current market capitalization of 5.30M, the company represents a significant player in its market. The stock is currently trading at $2.36 with a negativedaily change of 18.90%.
The company's 15 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.29, beta of 2.58, and 52-week price range from $2.01 to $6.47when evaluating investment opportunities.
Why Invest in HeartSciences Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Andrew Simpson
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.